Mindcure’s Kelsey Ramsden: Despite Market Slump, ‘Everything Is Moving In The Right Direction’ For Psychedelics Jan 25, 2022
Ibogaine Addiction Treatments & MDMA Assisted-Psychotherapy: MINDCURE & The State Of Psychedelic Therapeutics… Nov 23, 2021
CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together” Nov 16, 2021
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across… Oct 28, 2021
Could MDMA Be A Frontline Therapeutic For Women’s Sexual Disorders? MINDCURE CEO Kelsey Ramsden Says Yes Sep 29, 2021
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM’s Market… Apr 29, 2021
